Novartis AG:企業のM&A・事業提携・投資動向

◆英語タイトル:Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2102
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:980
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Novartis AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Novartis AG since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Novartis AG’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Novartis AG. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Novartis AG’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Novartis AG and its subsidiaries since 2007.
- Information about key financial and legal advisors for Novartis AG’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Novartis AG’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 10
Mergers and Acquisitions – Overview 10
Mergers and Acquisitions – Deal reports 11
CORPORATE VENTURING 96
Corporate Venturing – Overview 96
Corporate Venturing – Deal reports 97
PARTNERSHIP 162
Partnership – Overview 162
Partnership – Deal reports 163
DIVESTMENTS 891
Divestments – Overview 891
Divestments – Deal reports 892
PRIVATE EQUITY & OWNERSHIP 968
Private Equity and Ownership – Deal reports 968
APPENDIX 970
Contact Us 970
About MarketLine Financial Deals Database 970
Deal Definition and Methodology 972
About MarketLine 979

List of Tables
Table 1: Novartis AG M&A volume and value trend (2014-YTD2018)
Table 2: Novartis AG M&A activity by geography (2014-YTD2018)
Table 3: Novartis AG corporate venturing volume and value trend (2014-YTD2018)
Table 4: Novartis AG corporate venturing by geography (2014-YTD2018)
Table 5: Novartis AG partnership volume and value trend (2014-YTD2018)
Table 6: Novartis AG partnership trend by key deal type (2014-YTD2018)
Table 7: Novartis AG divestments volume and value trend (2014-YTD2018)
Table 8: Novartis AG divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Novartis AG M&A volume and value trend (2014-YTD2018)
Figure 2: Novartis AG M&A activity by geography (2014-YTD2018)
Figure 3: Novartis AG corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Novartis AG corporate venturing by geography (2014-YTD2018)
Figure 5: Novartis AG partnership volume and value trend (2014-YTD2018)
Figure 6: Novartis AG partnership trend by key deal type (2014-YTD2018)
Figure 7: Novartis AG divestments volume and value trend (2014-YTD2018)
Figure 8: Novartis AG divestments by geography (2014-YTD2018)

★海外企業調査レポート[Novartis AG:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd:企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Lennox International Inc.:企業の戦略・SWOT・財務情報
    Lennox International Inc. - Strategy, SWOT and Corporate Finance Report Summary Lennox International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • UCB Inc-製薬・医療分野:企業M&A・提携分析
    Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metad …
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Shri Lakshmi Defence Solutions Ltd.:企業の戦略・SWOT・財務情報
    Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Defence Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • MISC Berhad (MISC):石油・ガス:M&Aディール及び事業提携情報
    Summary MISC Bhd (MISC), a subsidiary of Petroliam Nasional Berhad (Petronas), is an international energy shipping and maritime conglomerate. The company is a fully integrated maritime, offshore floating solution, heavy engineering and logistics service provider. Its principal business activities in …
  • Bumi Armada Bhd (ARMADA):石油・ガス:M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • Gazprom Neft (SIBN):石油・ガス:M&Aディール及び事業提携情報
    Summary Gazprom Neft, a subsidiary of Gazprom, is an integrated oil and gas company. It explores for, develops, and produces crude oil and natural gas. The company operates in Khanty-Mansi and Yamalo-Nenets Autonomous Districts, and Tomsk, Omsk and Orenburg regions in Russia; and also has production …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Digi International, Inc. (DGII):企業の財務・戦略的SWOT分析
    Digi International, Inc. (DGII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報
    Summary Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. …
  • Virginia Electric and Power Co:企業の戦略的SWOT分析
    Virginia Electric and Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Walvax Biotechnology Co Ltd (300142):製薬・医療:M&Aディール及び事業提携情報
    Summary Walvax Biotechnology Co Ltd (Walvax) is a biopharmaceutical company that develops, produces and markets bio-medical products including vaccines and blood products. The company's products include haemophilus influenzae vaccine for the prevention of infectious diseases such as meningitis. Walv …
  • The Lubrizol Corporation-製薬・医療分野:企業M&A・提携分析
    Summary The Lubrizol Corporation (Lubrizol), a subsidiary of Berkshire Hathaway Inc., is a specialty chemical company that produces and supplies technologies to the global transportation, industrial, and consumer markets. Its products and services include engine additives, driveline additives, indus …
  • Berkem SA:企業の戦略・SWOT・財務情報
    Berkem SA - Strategy, SWOT and Corporate Finance Report Summary Berkem SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Catholic Health Initiatives:企業の戦略・SWOT・財務情報
    Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report Summary Catholic Health Initiatives - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Zydus Wellness Ltd (ZYDUSWELL):企業の財務・戦略的SWOT分析
    Zydus Wellness Ltd (ZYDUSWELL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sourcenext Corp (4344):企業の財務・戦略的SWOT分析
    Sourcenext Corp (4344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆